Drugs Made In America Acquisition II Corp.
DMIIR·NasdaqGM
0.07000.0000 (0.00%)today
As of Oct 22, 4:00 PM EDT · May be delayed up to 15 min · USD
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Previous close0.0700
Open0.0000
Day range—
52-week range—
Off day high0.00%
Off 52-week high0.00%
Volume13.00
Avg. volume (3M)—
Market cap—
EPS (TTM)—
Forward P/E—
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)—
Shares outstanding—
Short interest—
Earnings date—
Analyst target—
Profit margin0.00%
Against its peers
Compare in full ›| DMIIR | APUS | ANIP | ACXP | AMRX | JNJ | |
|---|---|---|---|---|---|---|
| Market cap | — | 4.36M | 1.67B | 6.31M | 7.10B | 635.07B |
| P/E (TTM) | — | — | 15.7 | — | 41.6 | 40.0 |
| Forward P/E | — | — | 7.2 | -0.6 | 16.9 | 22.7 |
| Price/book | -0.2 | 4.5 | 2.6 | 0.7 | 197.9 | 7.5 |
| Dividend yield | — | — | — | — | — | 2.00% |
| 1-year change | — | −84.04% | −21.74% | −82.49% | +94.12% | +40.55% |
| Today | 0.00% | −8.54% | −1.55% | −0.44% | −0.49% | −1.42% |
The closest companies by business. Prices may be delayed up to 15 min.
Latest news
All DMIIR news ›Drugs Made In America Acquisition II Corp. News — NASDAQ:DMII
Drugs Made In America Acquisition II Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar…
From articles in the 4Search news index.
In the news
1mentions in 30 days
1with it in the headline
Mixedsentiment
Mentioned with
People in the coverage
Most coverage from
-
tradingview.com1
Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 1 articles, not a forecast.